ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	7/27	167/7206	1.90222111844e-06
ko04217	Necroptosis	7/27	178/7206	2.91648709055e-06
ko05160	Hepatitis C	4/27	153/7206	0.00234357818997
ko04621	NOD-like receptor signaling pathway	4/27	157/7206	0.00257458966515
ko04612	Antigen processing and presentation	3/27	77/7206	0.0028533435954
ko05168	Herpes simplex infection	4/27	182/7206	0.00438459449728
ko05152	Tuberculosis	4/27	187/7206	0.00482884524448
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/27	191/7206	0.00520549709186
ko04658	Th1 and Th2 cell differentiation	3/27	96/7206	0.00531584939688
ko04659	Th17 cell differentiation	3/27	106/7206	0.00700131958337
ko04672	Intestinal immune network for IgA production	2/27	37/7206	0.0083059450877
ko05162	Measles	3/27	120/7206	0.0098436687841
ko05145	Toxoplasmosis	3/27	126/7206	0.0112403674076
ko03050	Proteasome	2/27	54/7206	0.0171630595374
ko05321	Inflammatory bowel disease (IBD)	2/27	56/7206	0.0183858754329
ko04622	RIG-I-like receptor signaling pathway	2/27	62/7206	0.022268219954
ko05161	Hepatitis B	3/27	173/7206	0.0260666871264
ko05140	Leishmaniasis	2/27	75/7206	0.03172107234
ko04060	Cytokine-cytokine receptor interaction	3/27	191/7206	0.0336087440405
ko05212	Pancreatic cancer	2/27	83/7206	0.0381961869177
ko04062	Chemokine signaling pathway	3/27	201/7206	0.0382443503907